Centric Compounding (Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial/Centric Compounding LLC)[...]

COMPANY ANNOUNCEMENT

Centric Compounding Issues Nationwide Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels

More Recalls, Market
Withdrawals, &
Safety Alerts

• Recalls, Market Withdrawals, & Safety Alerts
  • Recall Resources
  • Enforcement Reports
  • Industry Guidance For Recalls
  • Major Product Recalls

Summary

Company Announcement

FOR IMMEDIATE RELEASE - 9/9/2026 - Houston, Texas, Centric Compounding is voluntarily recalling 6 lots of Glutathione 200mg/mL, Myer's Cocktail, and Tri-Immune Boost injectable vials to the consumer level. The products have been found to be compounded with a Glutathione API containing elevated endotoxin levels.

Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. Centric Compounding has received 9 reports of fever, chills, chest pain, nausea/vomiting, headache, and/or malaise.

The products are used to support immunity, fatigue, and general wellness and are packaged in 30mL multidose vials. The affected Glutathione, Myer's Cocktail, and Tri-Immune Boost lots include the following lot numbers and expiration dates:

These products were distributed Nationwide to patients via home delivery and delivery to prescribers.

Centric Compounding is notifying its distributors and customers by email and is arranging for replacement of all recalled products. Consumers that have Glutathione, Myer's Cocktail, and Tri-Immune Boost which is being recalled should stop using and discard any affected vials.

Consumers with questions regarding this recall can contact Centric Compounding by phone at 833-777-6664 or [email protected] on Monday through Friday from 9am to 5pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

• Content current as of:

  09/13/2026

• Regulated Product(s)

  • Drugs

• Follow FDA

  • Follow @US_FDAon X
  • Follow FDAon Facebook
  • Follow @FDArecallson X
  • Recent Recalled Product Photos on FDA's Flickr Photostream